RK

Rakesh Kalla

Director Director DIN 01769406
DIN 01769406 First appointment Sep 2007 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2007
Shareholding value β€’β€’β€’β€’ Premium profile

About Rakesh Kalla

Data last updated:

Rakesh Kalla was a Director at Cytoage Labs Private Limited (2007–2013) and Director at Alpic Formulations Private Limited (from 2007). The companies operate in Trading.

DIN 01769406
Primary Designation Director
Industry Trading
First Appointment 28 Sep 2007
Oldest Company Age 19 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cytoage Labs Private Limited U24236RJ2007PTC025462
Director11 Dec 20072007Strike Off
Alpic Formulations Private Limited U24232RJ2007PTC025091
Director28 Sep 20072007₹38.4 Lakh (FY 2018)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Alpic Formulations Private Limited
Cytoage Labs Private Limited
Premium access

Shareholding and investment profile for Rakesh Kalla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Kalla

Rakesh Kalla was first appointed on 28 Sep 2007 as Director at Alpic Formulations Private Limited.

Rakesh Kalla held 2 earlier board appointments: Cytoage Labs Private Limited (Director, 11 Dec 2007 to 12 Apr 2013); Alpic Formulations Private Limited (Director, from 28 Sep 2007).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available